1982
DOI: 10.1111/j.1749-6632.1982.tb26845.x
|View full text |Cite
|
Sign up to set email alerts
|

Metabolism of Oxygen Derivatives in Down's Syndrome*

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
69
1
1

Year Published

1987
1987
2012
2012

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 178 publications
(77 citation statements)
references
References 46 publications
6
69
1
1
Order By: Relevance
“…7). Several investigators have proposed that the triplication of Cu/Zn-SOD in Ts16 mice and Down's syndrome individuals results in an elevated level of ROS (Sinet, 1982;Groner et al, 1994). Furthermore, in transgenic mice with an elevated level of Cu/Zn-SOD, a disruption in cellular ROS metabolism has been demonstrated (Avraham et al, 1988).…”
Section: R E T R a C T E Dmentioning
confidence: 99%
“…7). Several investigators have proposed that the triplication of Cu/Zn-SOD in Ts16 mice and Down's syndrome individuals results in an elevated level of ROS (Sinet, 1982;Groner et al, 1994). Furthermore, in transgenic mice with an elevated level of Cu/Zn-SOD, a disruption in cellular ROS metabolism has been demonstrated (Avraham et al, 1988).…”
Section: R E T R a C T E Dmentioning
confidence: 99%
“…There is evidence that the hydroxyl radical is the ultimate toxic ROS species compared to the superoxide radical [5], and that its formation is prevented by the destruction of H 2 O 2 by catalase [17]. Overproduction of SOD-1 may increase the rate of H 2 O 2 generation [25], leading to a secondary increase in hydroxyl radicals [26,31] that might result in an excess of hydroxyl radicals, which may be responsible for the cytotoxicity of alloxan in the hSOD-1 Tg mice.…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand deleterious effects of SOD overexpression are well known, as they have been demonstrated in many settings including cell lines (Groner et al, 1986) and transgenic animals (Avraham et al, 1988;Ceballos-Picot et al, 1991). Increased oxidative stress in Down's syndrome seems to be associated with SOD-1 overexpression (Sinet, 1982). Dose-dependency curve for SOD and also its mimetics in different experimental settings is 'bell-shaped', i.e.…”
Section: Antioxidant Therapies In Neurodegenerative Diseases: Rationamentioning
confidence: 99%